Naomi Birbach is a partner in Goodwin’s IP Litigation group and focuses her practice on patent matters across a wide variety of industries, including pharmaceuticals, electronic devices, display systems, and software. Naomi has represented clients in numerous patent infringement lawsuits in federal courts nationwide and has significant trial experience. She also represents clients before the Patent Trial and Appeal Board (PTAB) in post-grant proceedings such as inter partes reviews (IPRs).





Naomi has experience representing companies in all stages of patent litigation, from pre-suit investigation through trial and appeal. Matter highlights include:

Representative Technology Experience:

  • Ultravision Technologies, LLC v. Shenzhen Absen Optoelectronic Co., Ltd. (E.D. Tex.): Represented defendants as a member of the trial team against claims of patent infringement relating to LED displays. The jury found that Absen’s products did not infringe the asserted patents and that the asserted patents were invalid
  • Gabara v. Facebook, Inc. (S.D.N.Y.): Represented Facebook in a multi-patent litigation involving aspects of Facebook Messenger and 3D Photos. The District Court granted Facebook’s motion to dismiss for failure to claim patent-eligible subject matter
  • Leviton Mfg. Co., Inc. v. Pass & Seymour, Inc.(E.D.N.Y.): Representing defendant Pass & Seymour in a long-running dispute involving P&S’s core technology, ground-fault circuit interrupters (GFCIs), between the two market leaders in the U.S. GFCI market

Representative Pharmaceuticals Experience:

  • Otsuka Pharmaceutical Co., Ltd. v. Teva Pharmaceuticals USA, Inc.(D. Del.): Representing Teva in a pending patent infringement action filed by Otsuka and Lundbeck under the Hatch-Waxman Act relating to Teva’s filing of an abbreviated new drug application for a generic version of REXULTI®
  • Cosmo Technologies Ltd. et al. v. Actavis Laboratories FL, Inc. (D. Del.): Represented Actavis in a patent infringement action filed by Cosmo and Valeant under the Hatch-Waxman Act relating to Actavis’s filing of an abbreviated new drug application for generic versions of Valeant’s drug UCERIS®. The District Court ruled at trial that Actavis’s product did not infringe the asserted patents and the Federal Circuit affirmed
  • Otsuka Pharmaceutical Co., Ltd. v. Teva Pharmaceuticals USA, Inc.(D.N.J.): Represented Teva in a patent infringement action filed by Otsuka under the Hatch-Waxman Act relating to Teva’s filing of abbreviated new drug applications for generic versions of Otsuka’s drug ABILIFY®. Teva defeated a motion for a temporary restraining order, allowing Teva to launch its products. The case against Teva settled favorably before trial
Professional Activities

Naomi is member of the New York Intellectual Property Law Association (NYIPLA).

Professional Experience

Prior to entering law school, Naomi was a patent examiner at the U.S. Patent and Trademark Office.


Naomi has been selected for inclusion in The Legal 500 U.S. 2022.

Naomi has been recognized by The Best Lawyers in America Ones to Watch for her work in Litigation - Patent 2022.

Naomi was named to The Best Lawyers in America 2021: Ones to Watch.

In The News









JD, 2013
Georgetown University Law Center

(cum laude)

BA, Chemistry, 2008
Cornell University



New York
New Jersey
U.S. Patent and Trademark Office (USPTO)


U.S. District Court for the Southern District of New York
U.S. District Court for the Eastern District of New York
U.S. Court of Appeals for the Federal Circuit
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique